Resources from the same session
The real-world impact of genotyping in NSCLC
Presenter: Anne-Marie Baird
Session: Genotyping in NSCLC: Monitoring, germline alterations, minimal residual disease
Resources:
Slides
Webcast
Utility of genotyping in monitoring disease evolution and treatment response
Presenter: Rafal Dziadziuszko
Session: Genotyping in NSCLC: Monitoring, germline alterations, minimal residual disease
Resources:
Slides
Webcast
Value of genotyping in the assessment of minimum residual disease
Presenter: Luis Paz-Ares
Session: Genotyping in NSCLC: Monitoring, germline alterations, minimal residual disease
Resources:
Slides
Webcast